TG Therapeutics Investigational Site is a clinical research site located in Canton, Ohio, United States 44718.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
TG Therapeutics Investigational Site has participated in 1 clinical trials.
Therapeutic areas: Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma.
Sponsors: TG Therapeutics, Inc..
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
TG Therapeutics Investigational Site has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
TG Therapeutics Investigational Site has 1 clinical trials on record. Their work covers Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma.
TG Therapeutics Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.